Efficacy of Saccharomyces cerevisiae CNCM I-3856 as an add-on therapy for irritable bowel syndrome
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background The symptoms of irritable bowel syndrome (IBS) lead to considerable impairment of health-related quality of life and high health care costs. Available therapies are not efficient in treating the symptoms of IBS. Studies have shown the beneficial effects of Saccharomyces cerevisiae CNCM I-3856. Therefore, this study was done to evaluate the efficacy and safety of S. cerevisiae CNCM I-3856 in the treatment of IBS. Methods This was a prospective, randomized, placebo-controlled study. One hundred newly diagnosed subjects with IBS were subgrouped into IBS-D, IBS-C, and IBS-M and then randomized to the S. cerevisiae CNCM I-3856 and placebo groups. Saccharomyces cerevisiae/placebo was administered in addition to standard treatment for a period of 8 weeks. Subjects were assessed for improvement of abdominal pain and change in stool consistency using a 7-point Likert scale and Bristol stool scale respectively. Results The mean reduction of abdominal pain score in the S. cerevisiae CNCM I-3856 group was statistically significant when compared with the placebo group (p Conclusion The use of Saccharomyces cerevisiae CNCM I-3856 in IBS at a dose of 2 billion CFU twice daily for 8 weeks has shown to have an improvement in abdominal pain and stool consistency due to its analgesic and anti-inflammatory activity in subjects with IBS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the abdominal pain outcomes, we consider that Gayathri’s study [58] administered standard IBS therapy (antispasmodic dicyclomine) for two weeks along with a placebo twice daily for eight weeks during the trial, which might be a major source of heterogeneity in the analysis.”
Citations
Cites
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384
The epidemiology of irritable bowel syndrome
Card, T., Canavan, C., & West, J. (2014) · Clinical Epidemiology · doi:10.2147/clep.s40245 · Cited by 889
Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine
Saha, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i22.6759 · Cited by 500
Lovell, R. M., & Ford, A. C. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.131 · Cited by 412
Ghoshal, U. C., Abraham, P., Bhatt, C. B., Choudhuri, G., Bhatia, S. J., Shenoy, K. T., Banka, N. H., Bose, K. S. C., Bohidar, N. P., Chakravartty, K., et al. (2008) · PubMed · Cited by 193
Symptoms across the menstrual cycle in women with irritable bowel syndrome
Heitkemper, M. M., Cain, K. C., Jarrett, M. E., Burr, R. L., Hertig, V., & Bond, E. F. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07233.x · Cited by 165
Short-Chain Fatty Acids Stimulate Ileal Motility in Humans
Kamath, P. S., Phillips, S. F., & Zinsmeister, A. R. (1988) · Gastroenterology · doi:10.1016/s0016-5085(88)80068-4 · Cited by 158
Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice
Moayyedi, P., Mearin, F., Azpiroz, F., Andresen, V., Barbara, G., Corsetti, M., Emmanuel, A., Hungin, A. P. S., Layer, P., Stanghellini, V., et al. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617731968 · Cited by 135
Pineton de Chambrun, G., Neut, C., Chau, A., Cazaubiel, M., Pelerin, F., Justen, P., & Desreumaux, P. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.11.007 · Cited by 120
Jawhara, S., Habib, K., Maggiotto, F., Pignede, G., Vandekerckove, P., Maes, E., Dubuquoy, L., Fontaine, T., Guerardel, Y., & Poulain, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040648 · Cited by 113
Systematic review: complementary and alternative medicine in the irritable bowel syndrome
HUSSAIN, Z., & QUIGLEY, E. M. M. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02776.x · Cited by 113
Spiller, R., Pélerin, F., Cayzeele Decherf, A., Maudet, C., Housez, B., Cazaubiel, M., & Jüsten, P. (2016) · United European Gastroenterology Journal · doi:10.1177/2050640615602571 · Cited by 87
Rahman, M. M., Mahadeva, S., & Ghoshal, U. C. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i37.6788 · Cited by 69
Cayzeele-Decherf, A., Pélerin, F., Leuillet, S., Douillard, B., Housez, B., Cazaubiel, M., Jacobson, G. K., Jüsten, P., & Desreumaux, P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i2.336 · Cited by 58
Epidemiology of irritable bowel syndrome.
Endo, Y., Shoji, T., & Fukudo, S. (2015) · PubMed Central · Cited by 40
Benefits from Long-Term Treatment in Irritable Bowel Syndrome
Evangelista, S. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/936960 · Cited by 28
Rousseaux, C., Bouguen, G., Dubuquoy, C., Dubuquoy, L., Vandekerckove, P., & Desreumaux, P. (2010) · Gastroenterology · doi:10.1016/s0016-5085(10)60232-6 · Cited by 5
Cited by
Intestinal mycobiota in health and diseases: from a disrupted equilibrium to clinical opportunities
Wu, X., Xia, Y., He, F., Zhu, C., & Ren, W. (2021) · Microbiome · doi:10.1186/s40168-021-01024-x · Cited by 162
Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis
Zhang, T., Zhang, C., Zhang, J., Sun, F., & Duan, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.859967 · Cited by 125
McFarland, L. V., Karakan, T., & Karataş, A. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101154 · Cited by 108
Napolitano, M., Fasulo, E., Ungaro, F., Massimino, L., Sinagra, E., Danese, S., & Mandarino, F. V. (2023) · Microorganisms · doi:10.3390/microorganisms11102369 · Cited by 107
Wu, Y., Li, Y., Zheng, Q., & Li, L. (2024) · Nutrients · doi:10.3390/nu16132114 · Cited by 81
Metadata
- Authors
- Gayathri, R., Aruna, T., Malar, S., Shilpa, B., & Dhanasekar, K. R.
- Affiliations
- Government Kilpauk Medical College (IN)
- Corresponding author
- Dhanasekar, Karukkupalayam Ramasamy
- Venue
- International Journal of Colorectal Disease
- Published
- 2019-12-05
- Volume
- 35
- Issue
- 1
- Pages
- 139-145
- ISSN
- 0179-1958 (ISSN-L)
- 1432-1262
- OpenAlex
- W2993080746
- Cited by
- 33
- References
- 17
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 5 · 2023: 7 · 2022: 8 · 2021: 7 · 2020: 2
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- International Journal of Colorectal Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- irritable bowel syndrome, probiotics, adjunctive therapy, abdominal pain, stool consistency, diarrhea-predominant irritable bowel syndrome, irritable bowel syndrome with constipation, IBS-M, health-related quality of life, anti-inflammatory activity, analgesic activity
- MeSH terms
- Adult, Feces, Female, Humans, Male, Saccharomyces cerevisiae, Abdominal Pain, Treatment Outcome, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.